1. Home
  2. GIL vs ERAS Comparison

GIL vs ERAS Comparison

Compare GIL & ERAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gildan Activewear Inc. Sub. Vot.

GIL

Gildan Activewear Inc. Sub. Vot.

N/A

Current Price

$32.99

Market Cap

6.1B

ML Signal

N/A

Logo Erasca Inc.

ERAS

Erasca Inc.

N/A

Current Price

$13.60

Market Cap

6.3B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
GIL
ERAS
Founded
1946
2018
Country
Canada
United States
Employees
N/A
N/A
Industry
Building Products
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.1B
6.3B
IPO Year
1999
2021

Fundamental Metrics

Financial Performance
Metric
GIL
ERAS
Price
$32.99
$13.60
Analyst Decision
Buy
Buy
Analyst Count
12
10
Target Price
★ $50.88
$25.10
AVG Volume (30 Days)
1.9M
★ 5.1M
Earning Date
11-05-2026
11-12-2026
Dividend Yield
★ 2.93%
N/A
EPS Growth
N/A
★ 36.23
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$53.26
N/A
Revenue Next Year
$0.39
N/A
P/E Ratio
$23.11
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$31.34
$2.81
52 Week High
$73.70
$24.28

Technical Indicators

Market Signals
Indicator
GIL
ERAS
Relative Strength Index (RSI) 33.25 42.80
Support Level $31.34 $13.18
Resistance Level $43.16 $15.71
Average True Range (ATR) 1.61 1.31
MACD -0.16 -0.13
Stochastic Oscillator 17.51 14.12

Price Performance

Historical Comparison
GIL
ERAS

About GIL Gildan Activewear Inc. Sub. Vot.

Gildan is a vertically integrated designer and manufacturer of basic apparel, including T-shirts, underwear, socks, and hosiery. It is a leader in blank T-shirts, sweatshirts, and other apparel to wholesalers, major clothing brands, and printers (printwear). Gildan also sells branded clothing through retail and direct-to-consumer channels, a business that was greatly enhanced by the Hanesbrands acquisition in 2025. Gildan's labels include Hanes, Bali, Maidenform, Playtex, Gildan, American Apparel, Comfort Colors, and Goldtoe. Gildan produces most of its clothing at factories in Latin America but has been ramping up production at its new facility in Bangladesh. Incorporated in 1984, the Montreal-based company operates internationally but generated 90% of its sales in the US in 2025.

About ERAS Erasca Inc.

Erasca Inc is a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. Its focused RAS/MAPK pathway pipeline comprises modality-agnostic programs aligned with three therapeutic strategies of: targeting key upstream and downstream signaling nodes in the RAS/MAPK pathway; targeting RAS directly; and targeting escape routes that emerge in response to treatment. Its pipeline includes two clinical-stage programs (ERAS-0015, a pan-RAS molecular glue; and ERAS-4001, a pan-KRAS inhibitor), and ERAS-12, a discovery-stage program.

Share on Social Networks: